Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
42.44
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GeneDx Holdings Corp. - Class A Common Stock
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
GeneDx Announces Evolution of Executive Leadership Team
September 11, 2023
Melanie Duquette joining team as Chief Growth Officer to drive commercial excellence, Jennifer Brendel to take new role as Chief of Corporate Affairs amplifying the GeneDx brand and leadership...
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Where GeneDx Hldgs Stands With Analysts
August 09, 2023
Via
Benzinga
GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
September 06, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
August 23, 2023
Wednesday's session saw 150 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 22, 2023
On Tuesday, 210 companies reached new 52-week lows.
Via
Benzinga
Recap: GeneDx Hldgs Q1 Earnings
May 09, 2023
Via
Benzinga
GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine
August 21, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
Earnings Preview: GeneDx Hldgs
May 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
August 08, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
August 07, 2023
Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms
From
GeneDx Holdings Corp.; PacBio
Via
GlobeNewswire
GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options
July 19, 2023
Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patients
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 18, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium
June 28, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
June 26, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
June 20, 2023
Eight state Medicaid programs now cover rWGS in the pediatric inpatient setting, with active bills in other states
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Participate in Upcoming Investor Conferences in June
May 24, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
May 23, 2023
Keynote session to highlight value of GeneDx genomic data and clinical insights to accelerate genetic neurodevelopmental disorder pipeline for Mahzi Therapeutics
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 22, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
May 12, 2023
On Friday, 199 companies reached new 52-week lows.
Via
Benzinga
GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
May 09, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option
May 04, 2023
New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
GeneDx Announces Clarification Regarding CUSIP Number for Public Warrant Holders
May 03, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
Why GeneDx Holdings Stock Lagged the Market Today
April 28, 2023
A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.
Via
The Motley Fool
GeneDx Announces Reverse Stock Split
April 28, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
GeneDx to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 18, 2023
From
GeneDx Holdings Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.